Matches in Nanopublications for { ?s ?p "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP836503.RAqk6zID8oJn2KIb7qnhwX8ci4v9lIFn8dKinDO1pDS5c130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836503.RAqk6zID8oJn2KIb7qnhwX8ci4v9lIFn8dKinDO1pDS5c130_provenance.
- NP524909.RAeo_eJD8ficOnY8abR3JmeVb6I0a51mHJol6CoU3GMZk130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524909.RAeo_eJD8ficOnY8abR3JmeVb6I0a51mHJol6CoU3GMZk130_provenance.
- NP232217.RAbNFDlR41vYNIupg1UW27cSKMw6wx4CZaG026cacC0VI130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232217.RAbNFDlR41vYNIupg1UW27cSKMw6wx4CZaG026cacC0VI130_provenance.
- NP617345.RA6Con6PQE1bbCDUwZiMagz3XRNpO9mVUVSXmV75Nd5LU130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617345.RA6Con6PQE1bbCDUwZiMagz3XRNpO9mVUVSXmV75Nd5LU130_provenance.
- NP665871.RA8UCiB3gG2yrp1nhEZfA5owOkIUPwrbusc6DMb2eToQk130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665871.RA8UCiB3gG2yrp1nhEZfA5owOkIUPwrbusc6DMb2eToQk130_provenance.
- assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP394010.RAsuMMQAEDPlQJiQPyP0OdyrUqRmxZbO53ZsvikgLp6JQ130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394010.RAsuMMQAEDPlQJiQPyP0OdyrUqRmxZbO53ZsvikgLp6JQ130_provenance.
- NP890177.RAtoYAxzQa7nSppBe4UxM2lb_EZc0lisI65B5cohFdD7g130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890177.RAtoYAxzQa7nSppBe4UxM2lb_EZc0lisI65B5cohFdD7g130_provenance.
- NP528866.RAg3pPA_MLvQ9lFh5A6FPZyO30H97KpHH-QrlPnJreh6w130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528866.RAg3pPA_MLvQ9lFh5A6FPZyO30H97KpHH-QrlPnJreh6w130_provenance.
- NP528870.RAnKxysxvpfFgl1bNK8161STkHMI5cgpj0nvNn3x4Dugg130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528870.RAnKxysxvpfFgl1bNK8161STkHMI5cgpj0nvNn3x4Dugg130_provenance.
- NP807290.RAEiRLmwVtgnnjBlPf1oiqR4khG__U58dK-_q1UPessLE130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807290.RAEiRLmwVtgnnjBlPf1oiqR4khG__U58dK-_q1UPessLE130_provenance.
- NP528865.RAMzYxsN0gYM9n9R9aeNnwb3vZqeGRqrNH5pFTacH3SXk130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528865.RAMzYxsN0gYM9n9R9aeNnwb3vZqeGRqrNH5pFTacH3SXk130_provenance.
- NP528864.RA2dgK8pm_ajaAbROS4fOOYEAto_JWwc7SMpK5jfsnZXs130_assertion description "[JAK2 mutation was associated in PV erythroblasts with cytokine-independent activation of the JAK2 effectors Akt/PKB and ERK/MAP and with a deregulated expression of c-FLIP(short), a potent cellular inhibitor of death receptor-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528864.RA2dgK8pm_ajaAbROS4fOOYEAto_JWwc7SMpK5jfsnZXs130_provenance.